vs
Side-by-side financial comparison of Sensus Healthcare, Inc. (SRTS) and TON Strategy Co (TONX). Click either name above to swap in a different company.
TON Strategy Co is the larger business by last-quarter revenue ($5.7M vs $4.9M, roughly 1.2× Sensus Healthcare, Inc.). Sensus Healthcare, Inc. runs the higher net margin — -64.1% vs -3968.6%, a 3904.4% gap on every dollar of revenue. On growth, TON Strategy Co posted the faster year-over-year revenue change (694.2% vs -62.2%). Sensus Healthcare, Inc. produced more free cash flow last quarter ($-2.4M vs $-8.0M). Over the past eight quarters, TON Strategy Co's revenue compounded faster (46.1% CAGR vs -31.9%).
Sensus Healthcare, Inc. is a medical technology company that designs, manufactures and commercializes innovative non-invasive superficial radiation therapy systems. Its products are primarily used for treating non-melanoma skin cancers, keloids, and select cosmetic dermatology conditions, serving healthcare providers and clinical facilities worldwide.
SRTS vs TONX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $4.9M | $5.7M |
| Net Profit | $-3.2M | $-227.9M |
| Gross Margin | 38.4% | 64.3% |
| Operating Margin | -63.8% | -159.2% |
| Net Margin | -64.1% | -3968.6% |
| Revenue YoY | -62.2% | 694.2% |
| Net Profit YoY | -304.9% | -7047.9% |
| EPS (diluted) | $-0.19 | $-3.89 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $4.9M | $5.7M | ||
| Q3 25 | $6.9M | $3.6M | ||
| Q2 25 | $7.3M | $2.1M | ||
| Q1 25 | $8.3M | $1.3M | ||
| Q4 24 | $13.1M | $723.0K | ||
| Q3 24 | $8.8M | — | ||
| Q2 24 | $9.2M | — | ||
| Q1 24 | $10.7M | — |
| Q4 25 | $-3.2M | $-227.9M | ||
| Q3 25 | $-943.0K | $84.3M | ||
| Q2 25 | $-1.0M | $-2.4M | ||
| Q1 25 | $-2.6M | $-2.6M | ||
| Q4 24 | $1.5M | $-3.2M | ||
| Q3 24 | $1.2M | — | ||
| Q2 24 | $1.6M | — | ||
| Q1 24 | $2.3M | — |
| Q4 25 | 38.4% | 64.3% | ||
| Q3 25 | 39.4% | 75.4% | ||
| Q2 25 | 39.7% | 71.2% | ||
| Q1 25 | 52.2% | 73.4% | ||
| Q4 24 | 54.4% | 81.5% | ||
| Q3 24 | 59.3% | — | ||
| Q2 24 | 58.7% | — | ||
| Q1 24 | 62.5% | — |
| Q4 25 | -63.8% | -159.2% | ||
| Q3 25 | -37.3% | -601.5% | ||
| Q2 25 | -26.6% | -138.2% | ||
| Q1 25 | -31.7% | -203.8% | ||
| Q4 24 | 13.2% | -513.1% | ||
| Q3 24 | 16.9% | — | ||
| Q2 24 | 21.5% | — | ||
| Q1 24 | 27.1% | — |
| Q4 25 | -64.1% | -3968.6% | ||
| Q3 25 | -13.7% | 2336.8% | ||
| Q2 25 | -14.2% | -111.9% | ||
| Q1 25 | -30.8% | -196.5% | ||
| Q4 24 | 11.8% | -440.9% | ||
| Q3 24 | 13.7% | — | ||
| Q2 24 | 17.4% | — | ||
| Q1 24 | 21.3% | — |
| Q4 25 | $-0.19 | $-3.89 | ||
| Q3 25 | $-0.06 | $2.23 | ||
| Q2 25 | $-0.06 | $-1.79 | ||
| Q1 25 | $-0.16 | $-2.51 | ||
| Q4 24 | $0.10 | $10.41 | ||
| Q3 24 | $0.07 | — | ||
| Q2 24 | $0.10 | — | ||
| Q1 24 | $0.14 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $22.1M | $39.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $48.1M | $406.5M |
| Total Assets | $53.0M | $411.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $22.1M | $39.5M | ||
| Q3 25 | $24.5M | $53.9M | ||
| Q2 25 | $22.2M | $10.4M | ||
| Q1 25 | $19.1M | $12.2M | ||
| Q4 24 | $22.1M | $12.5M | ||
| Q3 24 | $22.6M | — | ||
| Q2 24 | $19.0M | — | ||
| Q1 24 | $14.7M | — |
| Q4 25 | $48.1M | $406.5M | ||
| Q3 25 | $51.2M | $639.1M | ||
| Q2 25 | $52.1M | $19.4M | ||
| Q1 25 | $53.0M | $14.6M | ||
| Q4 24 | $55.8M | $16.2M | ||
| Q3 24 | $54.1M | — | ||
| Q2 24 | $52.9M | — | ||
| Q1 24 | $51.2M | — |
| Q4 25 | $53.0M | $411.2M | ||
| Q3 25 | $58.3M | $661.9M | ||
| Q2 25 | $58.9M | $23.7M | ||
| Q1 25 | $60.2M | $18.4M | ||
| Q4 24 | $62.2M | $20.6M | ||
| Q3 24 | $59.9M | — | ||
| Q2 24 | $58.2M | — | ||
| Q1 24 | $57.3M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.2M | $-8.0M |
| Free Cash FlowOCF − Capex | $-2.4M | $-8.0M |
| FCF MarginFCF / Revenue | -47.9% | -139.3% |
| Capex IntensityCapex / Revenue | 3.2% | 0.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $332.0K | $-20.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.2M | $-8.0M | ||
| Q3 25 | $2.3M | $-9.4M | ||
| Q2 25 | $3.1M | $-2.3M | ||
| Q1 25 | $-2.7M | $-1.1M | ||
| Q4 24 | $-827.0K | $-1.9M | ||
| Q3 24 | $4.0M | — | ||
| Q2 24 | $4.2M | — | ||
| Q1 24 | $-8.2M | — |
| Q4 25 | $-2.4M | $-8.0M | ||
| Q3 25 | $2.3M | $-9.4M | ||
| Q2 25 | $3.1M | $-2.3M | ||
| Q1 25 | $-2.7M | $-1.1M | ||
| Q4 24 | $-1.1M | $-2.0M | ||
| Q3 24 | $3.6M | — | ||
| Q2 24 | $4.2M | — | ||
| Q1 24 | $-8.4M | — |
| Q4 25 | -47.9% | -139.3% | ||
| Q3 25 | 33.3% | -261.4% | ||
| Q2 25 | 42.2% | -107.8% | ||
| Q1 25 | -32.2% | -87.0% | ||
| Q4 24 | -8.6% | -279.9% | ||
| Q3 24 | 40.9% | — | ||
| Q2 24 | 45.8% | — | ||
| Q1 24 | -79.0% | — |
| Q4 25 | 3.2% | 0.1% | ||
| Q3 25 | 0.1% | 0.4% | ||
| Q2 25 | 0.4% | 0.1% | ||
| Q1 25 | 0.1% | 5.1% | ||
| Q4 24 | 2.3% | 22.1% | ||
| Q3 24 | 3.8% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 2.2% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | -0.11× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -0.53× | — | ||
| Q3 24 | 3.25× | — | ||
| Q2 24 | 2.62× | — | ||
| Q1 24 | -3.60× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SRTS
| Products | $2.8M | 57% |
| Other | $2.1M | 43% |
TONX
| Market Live | $4.8M | 83% |
| Other | $960.0K | 17% |
